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Abstract
Background: Hemin, the oxidized form of heme, accumulates in intracranial hematomas and is a
potent oxidant. Growing evidence suggests that it contributes to delayed injury to surrounding
tissue, and that this process is affected by the heme oxygenase enzymes. In a prior study, heme
oxygenase-2 gene deletion increased the vulnerability of cultured cortical astrocytes to hemin. The
present study tested the effect of HO-2 gene deletion on protein oxidation, reactive oxygen
species formation, and cell viability after mixed cortical neuron/astrocyte cultures were incubated
with neurotoxic concentrations of hemin.
Results:  Continuous exposure of wild-type cultures to 1–10 µM hemin for 14 h produced
concentration-dependent neuronal death, as detected by both LDH release and fluorescence
intensity after propidium iodide staining, with an EC50 of 1–2 µM; astrocytes were not injured by
these low hemin concentrations. Cell death was consistently reduced by at least 60% in knockout
cultures. Exposure to hemin for 4 hours, a time point that preceded cell lysis, increased protein
oxidation in wild-type cultures, as detected by staining of immunoblots for protein carbonyl groups.
At 10 µM hemin, carbonylation was increased 2.3-fold compared with control sister cultures
subjected to medium exchanges only; this effect was reduced by about two-thirds in knockout
cultures. Cellular reactive oxygen species, detected by fluorescence intensity after
dihydrorhodamine 123 (DHR) staining, was markedly increased by hemin in wild-type cultures and
was localized to neuronal cell bodies and processes. In contrast, DHR fluorescence intensity in
knockout cultures did not differ from that of sham-washed controls. Neuronal death in wild-type
cultures was almost completely prevented by the lipid-soluble iron chelator phenanthroline;
deferoxamine had a weaker but significant effect.
Conclusions: These results suggest that HO-2 gene deletion protects neurons in mixed neuron-
astrocyte cultures from heme-mediated oxidative injury. Selective inhibition of neuronal HO-2 may
have a beneficial effect after CNS hemorrhage.
Published: 17 September 2004
BMC Neuroscience 2004, 5:34 doi:10.1186/1471-2202-5-34
Received: 30 June 2004
Accepted: 17 September 2004
This article is available from: http://www.biomedcentral.com/1471-2202/5/34
© 2004 Regan et al; licensee BioMed Central Ltd. 
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Neuroscience 2004, 5:34 http://www.biomedcentral.com/1471-2202/5/34
Page 2 of 8
(page number not for citation purposes)
Background
Hemin is a potent oxidant that accumulates in intracra-
nial hematomas and may contribute to neural cell injury
[1,2]. It is also the preferred substrate for heme oxygenase-
2, the constitutively-expressed isoform that accounts for
most CNS heme oxygenase (HO) under normal condi-
tions [3]. In pathologic states, HO frequently has an anti-
oxidant effect, putatively due to the protection provided
by increased cellular bilirubin, decreased heme, and up-
regulation of other antioxidants [4-7]. However, in mod-
els that are relevant to CNS hemorrhage, HO inhibitors
have surprisingly been found to be protective [8-10].
All HO inhibitors that are currently available have numer-
ous non-specific actions that may complicate the interpre-
tation of experimental results, including inhibition of
nitric oxide synthase and guanyl cyclase, and modifica-
tion of voltage-gated calcium currents [11-14]. Some may
also have a direct antioxidant effect that is unrelated to
HO inhibition [15]. In order to investigate HO-2 in heme-
mediated injury more specifically, we have cultured neu-
rons and astrocytes derived from HO-2 knockout mice
and genetically-similar wild type controls. In recent stud-
ies, we observed that astrocytes derived from mutant mice
were more vulnerable to hemin [16]. Conversely, HO-2
gene deletion decreased the vulnerability of neurons to
hemoglobin [17]. Neither wild type nor knockout astro-
cytes were injured by hemoglobin at the micromolar con-
centrations that are feasible in vitro. HO-2 gene deletion
per se did not result in a compensatory increase in HO-1
in these cultures, and produced minimal or no change in
other cellular antioxidants [16,17].
The disparate effects of HO-2 gene deletion on hemin tox-
icity to astrocytes and hemoglobin toxicity to neurons
may reflect the inability of neurons to tolerate the prod-
ucts of heme metabolism, i.e. iron, carbon monoxide, and
bilirubin. Alternatively, it may reflect the different oxidant
properties of hemin and hemoglobin. Although the oxi-
dant effect of hemoglobin may be due in part to hemin
release to membrane lipids [18], other mechanisms may
also contribute. Extracellular hemoglobin undergoes
autoxidation, which produces superoxide [19]. In addi-
tion to being an oxidant, superoxide reacts with globin
amino acids in a complex fashion to generate a variety of
reactive species, including thiyl radicals, hydroxyl radicals,
and hydrogen peroxide [20,21]. It is also noteworthy that
hemoglobin is highly water soluble while hemin is quite
lipophilic; their accumulation in separate cellular com-
partments may lead to a different pattern of site-specific
oxidative damage [22,23].
The present study was designed to test the effect of HO-2
gene deletion on the oxidative neuronal injury produced
by extracellular hemin. We specifically tested the hypoth-
esis that targeted deletion of the HO-2 gene attenuated
oxidative cell injury in a primary cell culture model of
hemin toxicity.
Results
Effect of HO-2 gene deletion on hemin neurotoxicity
In preliminary experiments, we observed that overnight
(14 h) exposure to low micromolar concentrations of
hemin consistently produced morphologic evidence of
neuronal injury in wild-type cultures (Fig. 1). This time
interval was therefore used for cytotoxicity studies. Con-
sistent with prior observations in pure astrocyte cultures
[24], no morphologic evidence of injury was observed in
the astrocyte monolayer at hemin concentrations up to 10
µM. In order to specifically assess neuronal injury in this
study, the concentrations used were limited to this range.
In wild-type cultures, cell injury as quantified by LDH
release was observed at 1 µM hemin and then increased
exponentially, to release of 69.7 ± 8.6% of neuronal LDH
at 3 µM (Fig 2A). The calculated EC50 was 1.85 µM. LDH
release was significantly reduced in knockout cultures
subjected to the same treatment. At 3 µM hemin, only
12.6 ± 4.1% of LDH had been released at this time point.
Control experiments demonstrated that these low hemin
concentrations do not interfere with the LDH assay.
Cell death was also quantified by analysis of fluorescence
intensity after staining cultures with propidium iodide.
Using this method, widespread neuronal death was also
observed at 3–10 µM hemin in wild type cultures, and the
calculated EC50  was 1.05 µM. Propidium staining of
nuclei was significantly reduced in cultures prepared from
HO-2 knockout mice (Fig. 2B). The maximal fluorescence
was produced by exposure to 10 µM hemin, which was
37.0 ± 3.2% of that observed in control sister cultures
treated with NMDA to kill all neurons.
Effect of HO-2 gene deletion on markers of cell oxidation
In order to assess reactive oxygen species formation after
hemin exposure, cultures were stained with 20 µM dihy-
drorhodamine 123 after 4 hour hemin exposure. This
time interval was used because it preceded cell lysis, and
therefore allowed cell retention of the reduced fluoro-
phore. A marked increase in fluorescence was observed in
cultures prepared from wild type mice (Fig. 3). This signal
was concentrated in neuronal cell bodies and processes.
In contrast, fluorescence in cultures prepared from HO-2
knockout mice was minimal, and did not exceed that
observed in cultures subjected to medium exchanges only.
In order to further investigate the effect of HO-2 gene
deletion on oxidative stress produced by hemin, cells were
harvested after 4 hour hemin exposure. Protein carbonyl
groups (i.e. aldehydes and ketones), which are markers of
oxidation, were then derivatized and detected with aBMC Neuroscience 2004, 5:34 http://www.biomedcentral.com/1471-2202/5/34
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dinitrophenylhydrazone antibody. Increased immunore-
activity was apparent in lysates of wild type cultures
treated with hemin (Figure 4). A prominent band was
present at approximately 44 kDa, along with a higher
molecular weight smear. At 10 µM hemin, the carbonyl
signal intensity in wild type cultures was 2.3-fold higher
than in cultures exposed to culture medium only, com-
pared with only 1.3-fold higher in knockout cultures.
Hemin neurotoxicity is attenuated by iron chelators
Based on our prior observations in astrocytes and neurob-
lastoma cells [24,25], we hypothesized that the toxic
product produced by hemin breakdown in primary
murine neurons was iron. In order to test this hypothesis,
the effect of iron chelators on hemin neurotoxicity in wild
type cultures was assessed. Most cell death, as detected by
both LDH release and PI staining, was prevented by
Morphologic changes in wild type and knockout cultures  exposed to hemin Figure 1
Morphologic changes in wild type and knockout cultures 
exposed to hemin. Phase contrast photomicrographs of cul-
tures exposed for 14 h to: A) Experimental medium 
(MEM10) only; neurons rest on a monolayer of astrocytes, 
and aggregate in groups which send out an array of proc-
esses; B) hemin 3 µM, wild type culture; most neurons and 
processes have degenerated; C) hemin 3 µM, knockout cul-
ture; neurons with intact processes persist.
A
B
C
Heme oxygenase-2 gene deletion attenuates the neurotoxic  effect of hemin Figure 2
Heme oxygenase-2 gene deletion attenuates the neurotoxic 
effect of hemin. Cultures were treated with indicated con-
centrations of hemin for 14 h. Injury was assessed by A) LDH 
activity in the medium, which is scaled to that in sister cul-
tures treated with 300 µM NMDA for 40 h (= 100), which 
releases essentially all neuronal LDH; B) fluorescence inten-
sity of cultures stained with propidium iodide, again scaled to 
that in sister cultures treated with NMDA. *P < 0.05, ***P < 
0.001 v. knockout cultures treated with same concentration 
of hemin, Bonferroni multiple comparisons test.
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concomitant treatment with phenanthroline, a lipid-solu-
ble iron chelator (Fig. 5). Deferoxamine, which is water
soluble, was less potent; its effect when applied at a
concentration tenfold greater than that of hemin reached
statistical significance only when injury was assessed by PI
staining.
Discussion
In prior experiments, we demonstrated that targeted dele-
tion of the HO-2 gene in primary neuron/astrocyte cul-
tures did not alter expression of HO-1, and had little or no
effect on other cellular antioxidants [17]. This simplified
system therefore permits investigation of HO-2 without
the confounding compensatory effects that have been
observed in whole animal models [26,27]. We have previ-
ously reported that HO-2 gene deletion increased the vul-
nerability of astrocytes to hemin, the preferred substrate
of HO, in cultures containing only astrocytes. The present
study targeted neurons in mixed neuron/astrocyte cul-
tures by using hemin concentrations that did not injure
Heme oxygenase-2 gene deletion reduces production of cellular reactive oxygen species, assessed with dihydrorhodamine 123 Figure 3
Heme oxygenase-2 gene deletion reduces production of cellular reactive oxygen species, assessed with dihydrorhodamine 123. 
Cultures were treated with 3 µM hemin for 4 h. Hemin was then washed out, and cultures were treated with 20 µM dihy-
drorhodamine 123 for 15 min and imaged. A) Wild type culture; fluorescence is localized to neuronal cell bodies and proc-
esses; B) Knockout culture; fluorescence is markedly diminished. Fluorescence intensity is quantified in arbitrary units.
W
T
K
O
0
2
4
6
8
1
0
1
2
Fluorescence Intensity
Dihydrorhodamine
A
BBMC Neuroscience 2004, 5:34 http://www.biomedcentral.com/1471-2202/5/34
Page 5 of 8
(page number not for citation purposes)
astrocytes [24]. In this model, the opposite was observed.
HO-2 deletion attenuated hemin-induced ROS formation
and reduced levels of oxidized proteins. Consistent with
the oxidative nature of hemin toxicity, neuronal death
was reduced in knockout cultures.
Although hemin is a highly reactive pro-oxidant, its break-
down as catalyzed by the heme oxygenases generates
biologically active and potentially toxic products. Prior in
vitro studies suggest that neurons are particularly vulnera-
ble to these, i.e. iron, carbon monoxide, and bilirubin
[28-30]. The present results suggest that when neurons are
provided with an excess of HO substrate, the toxicity of
breakdown products outweighs any benefit provided by
hemin removal. The protective effect of iron chelators sug-
gests that this phenomenon is at least partly due to iron
neurotoxicity. Inorganic iron is toxic to cultured cortical
neurons, with an EC50 of approximately 10 µM [17]. The
lower EC50  for hemin is not surprising, given its
lipophilicity and accumulation in cell membranes [31].
The latter phenomenon likely accounts for the greater effi-
cacy of phenanthroline, which unlike deferoxamine is
lipophilic. Deferoxamine is quite effective against hemo-
globin neurotoxicity in this culture system [32], suggest-
ing that hemoglobin releases its iron either in the medium
or in an aqueous cellular compartment.
Heme oxygenase-2 gene deletion reduces protein oxidation  in hemin-treated cultures Figure 4
Heme oxygenase-2 gene deletion reduces protein oxidation 
in hemin-treated cultures. Top: Representative immunoblot 
of protein lysates from wild type (WT) or HO-2 knockout 
(KO) neuron/astrocyte cultures treated for 4 h with indi-
cated hemin concentrations, stained with anti-DNP antibody 
to detect derivatized carbonyl groups. M: molecular weight 
standard with attached DNP residues. Bottom: The mean 
protein carbonyl signal intensity (± SEM, n = 5/condition) was 
normalized to that in wild-type cultures exposed to culture 
medium only (= 1.0) *P < 0.05; ***P < 0.001 versus signal in 
wild type cultures exposed to the same hemin concentration, 
Bonferroni multiple comparisons test.
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Effect of iron chelators on hemin toxicity Figure 5
Effect of iron chelators on hemin toxicity. Wild-type cultures 
were treated with 3 µM hemin for 14 h, alone or with indi-
cated concentrations of deferoxamine (DFO) or phenan-
throline (PHE). Injury was assessed by A) LDH activity in the 
culture medium, which is scaled to that in sister cultures 
treated with 300 µM NMDA for 40 h (= 100), which releases 
essentially all neuronal LDH; B) fluorescence intensity of cul-
tures stained with propidium iodide, again scaled to that in 
sister cultures treated with NMDA. ***P < 0.001 v. cultures 
treated with hemin only, Bonferroni multiple comparisons 
test.
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The present results are consistent with observations that
heme oxygenase inhibitors are protective in models of
CNS hemorrhage [2,8,9], in contrast to the beneficial
effect of HO in ischemia [33]. In a recent study, Koeppen
et al. [2] observed that repeated administration of tin mes-
oporphyrin protected thalamic neurons from the delayed
degeneration that occurred in tissue adjacent to injected
autologous blood. Similarly, Huang et al. [9] observed
that tin protoporphyrin attenuated edema formation after
stereotactic hemoglobin injection into the rat striatum. It
is noteworthy that the number of astrocytes per neuron is
significantly higher in the human brain than in rodents
[34]. The deleterious effect of HO inhibition on heme
mediated injury to astrocytes may therefore be less prom-
inent in animal models than in clinical intracerebral hem-
orrhage [35].
The disparate effect of HO on neurons and astrocytes
exposed to extracellular hemin suggests that it may be
somewhat difficult to target it effectively after CNS
hemorrhage. All currently available HO inhibitors inhibit
both HO-2, which is predominantly neuronal in vivo
[36], and HO-1, which is induced mainly in glial cells
[37]. The protection that these non-selective agents pro-
vide to neurons may be negated by their deleterious effect
on astrocytes. Further investigation is needed for the
development of strategies that would permit the selective
inhibition or down-regulation of HO-2 in neurons.
Conclusions
Targeted deletion of the heme oxygenase-2 gene mitigates
oxidative stress in cultured neurons exposed to hemin,
and is cytoprotective. Selective inhibition of neuronal
heme oxygenase may have a beneficial effect after CNS
hemorrhage.
Methods
Cell cultures
The HO-2 knockout mice which were used in this study
are descended from mutants produced by Poss et al. [38],
and have a C57BL/6 X 129/Sv genetic background. All
mice were obtained from our local breeding colony, and
were provided with food and water ad libitum and a 12
hour light/dark cycle. All breeding mice were the offspring
of heterozygotes. Genotype was determined by polymer-
ase chain reaction (PCR) using genomic DNA isolated
from tail clippings; primers were previously published
[17].
Cortical cell cultures were prepared from fetal mice at ges-
tational age 15–17 d as previously described [39]. Under
a dissecting microscope, cortices were dissected free from
other brain tissue, minced with forceps, and incubated in
medium containing 0.075%-acetylated trypsin at 37°C
for one hour. Tissue was then collected by low speed cen-
trifugation, and was dissociated by trituration through a
flamed Pasteur pipette in plating medium containing
Eagle's minimal essential medium (MEM), 5% fetal
bovine serum (Hyclone, Logan, UT), 5% heat inactivated
equine serum (Hyclone), glutamine (2 mM), and glucose
(23 mM). The cell suspension was diluted with additional
plating medium, and cells were plated on confluent
astrocyte cultures in 24-well plates (Primaria, Falcon) at a
density of 3 hemispheres/plate. Cultures were incubated
at 37°C in a humidified atmosphere containing 5% CO2/
95% air. Two-thirds of the culture medium was replaced
at days 4 and 8 in vitro with MEM containing 10% equine
serum, 2 mM glutamine, and 23 mM glucose. After ten
days in vitro this feeding procedure was performed daily.
Hemin exposure
Hemin was freshly prepared as a 1 mM stock solution and
was diluted to the desired concentration with minimal
essential medium containing 10 mM glucose (MEM10).
Experiments were conducted at 12–16 days in vitro.
Serum was washed out of cultures with MEM10 (> 1000X
dilution) prior to addition of hemin. Cultures were incu-
bated at 37°C in a 5% CO2 atmosphere for the entire
exposure interval.
Detection of reactive oxygen species
ROS formation was quantified by staining with dihy-
drorhodamine 123 (DHR, Molecular Probes, Eugene,
OR), which is a cell-permeable, non-fluorescent com-
pound that is oxidized by cellular peroxides to fluorescent
rhodamine [40]. Fluorescence intensity is directly propor-
tional to cellular oxidative stress. In order to prevent oxi-
dation of DHR by hemin in the medium, cultures were
washed free of hemin prior to DHR addition. After incu-
bation with 20 µM DHR in MEM10 for 15 min, the
medium was replaced, and cultures were imaged using a
Nikon inverted microscope with epifluorescence attach-
ment. Images were captured immediately after illumina-
tion (25 msec exposure). Photomicrographs of random
100X fields were analyzed with IPLab image analysis soft-
ware (Scanalytics, Inc., Fairfax, VA). The low fluorescence
in control cultures exposed to experimental medium only
was subtracted from mean values to define the signal asso-
ciated with hemin exposure.
Detection of protein oxidation
Protein oxidation was assessed using the Oxyblot™ kit
(Chemicon, Inc., Temecula, CA). At the end of the hemin
exposure interval, culture medium was aspirated, and cells
were washed and then harvested in 100 µl of lysis buffer
containing 210 mM mannitol, 70 mM sucrose, 5 mM
HEPES, 1 mM EDTA, and 0.1% sodium dodecyl sulfate.
Carbonyl groups were derivatized to 2, 4-dintrophenylhy-
drazone (DNP-hydrazone) by reaction with 2, 4-dinitro-
phenylhydrazine, following the manufacturer'sBMC Neuroscience 2004, 5:34 http://www.biomedcentral.com/1471-2202/5/34
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instructions. Proteins were then separated on a 12% poly-
acrylamide gel and were transferred onto a polyvinylidene
difluoride Imobilon-P transfer membrane filter (Milli-
pore, Billerica, MA) using a semidry transfer apparatus
(Bio-Rad, Hercules, CA). Carbonylated proteins were
detected with rabbit anti-DNP (1:150) followed by goat
anti-rabbit IgG (1:300). Immunoreactive proteins were
visualized using Super Signal West Femto Reagent (Pierce
Biotechnology, Rockford, IL) and Kodak ImageStation
400.
Quantification of cell death
After examination of cultures using phase contrast micro-
scopy, cell death was quantified by measurement of LDH
activity in the culture medium, as previously described
[41]. To facilitate comparisons, values were scaled to the
mean value in sister cultures exposed to NMDA 300 µM
for 40 h. This treatment releases essentially all neuronal
LDH in this system without injuring astrocytes [42]. Since
the low micromolar concentrations of hemin that were
used in this study do not injure cultured cortical astrocytes
[24], the contribution of astrocyte LDH to the total signal
is negligible.
Cell death was also quantified by staining with propidium
iodide (13 µg/ml for 15 min). When viewed with a rhod-
amine filter, the nuclei of cells with disrupted membranes
stain red, while cells with intact membranes exclude pro-
pidium. Random 100X fields were captured with a Nikon
Diaphot epifluorescence microscope and were analyzed
with IPLab image analysis software. As with LDH data, flu-
orescence intensity was scaled to that in sister cultures
treated with NMDA 300 µM for 40 h, which kills all neu-
rons. Propidium iodide fluorescence was not observed in
cells that had an astrocyte phenotype after treatment with
NMDA or hemin at the concentrations used in this study.
Abbreviations
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iodide; ROS: reactive oxygen species.
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